PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New, modified CRISPR protein can fit inside virus used for gene therapy

Novel enEbCas12a protein shows potential promise as gene-editing tool to one day treat disease

New, modified CRISPR protein can fit inside virus used for gene therapy
2024-05-30
(Press-News.org) Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian Wang and colleagues at Wuhan University, China, present these findings May 23rd in the open-access journal PLOS Biology.

Recent years have seen an explosion of research attempting to harness CRISPR gene-editing systems—which are found naturally in many bacteria as a defense against viruses—so they can be used as potential treatments for human disease. These systems rely on so-called CRISPR-associated (Cas) proteins, with Cas9 and Cas12a being the two most widely used types, each with their own quirks and strengths.

One promising idea is to package CRISPR proteins within a non-pathogenic virus, which could then deliver the proteins to target cells; there, they would modify specifically targeted DNA sequences to treat disease. However, the commonly used adeno-associated virus is small, and while some Cas9 proteins can fit inside, Cas12a proteins are typically too large.

Now, Wang and colleagues have identified a relatively small version of Cas12a, termed EbCas12a, that occurs naturally in a species of the Erysipelotrichia class of bacteria. By deliberately switching out one of the amino acid building blocks of the protein for another, they boosted its gene-editing efficiency. When applied to mammalian cells in a dish in the lab, this modified protein—dubbed enEbCas12a—shows gene-editing efficiency comparable to that of two other Cas12a proteins known for highly accurate gene editing.

The research team then demonstrated that enEbCas12a is small enough to be used for adeno-associated virus-based gene therapy. They modified enEbCas12a to target a specific cholesterol-associated gene, packaged it within the virus, and administered the virus to mice with high cholesterol. One month later, they found a significant reduction of blood cholesterol levels in the treated mice, compared to mice that did not receive the virus.

More research will be needed to determine if enEbCas12a could one day be used to address human disease. Nonetheless, these findings suggest it could be possible to use adeno-associated virus to deliver Cas12a proteins for gene therapy.

The authors add, “The novel compact enEbCas12a, along with its crRNA, can be packaged into an all-in-one AAV system for convenient gene editing in vitro and in vivo with high-fidelity, which can be very beneficial for future clinical applications and more tool developments including all-in-one AAV- based multi-gene editing, base editing, primer editing, etc.”

#####

In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002619

Citation: Wang H, Zhou J, Lei J, Mo G, Wu Y, Liu H, et al. (2024) Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system. PLoS Biol 22(5): e3002619. https://doi.org/10.1371/journal.pbio.3002619

Author Countries: China

Funding: This work was supported by the National Key R&D Program of China (2022YFA1303500 to LY), the National Natural Science Foundation of China (32101196 to PC, 32171210, 31870728 and 32371271 to LY), the Fundamental Research Funds for the Central Universities (2042022kf1189 to LY), the China Postdoctoral Science Foundation (2021TQ0253 and 2022M712468 to PC, 2022M722473 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

END


[Attachments] See images for this press release:
New, modified CRISPR protein can fit inside virus used for gene therapy New, modified CRISPR protein can fit inside virus used for gene therapy 2 New, modified CRISPR protein can fit inside virus used for gene therapy 3

ELSE PRESS RELEASES FROM THIS DATE:

Misleading COVID-19 headlines from mainstream sources did more harm on Facebook than fake news

2024-05-30
CAMBRIDGE, Mass., May 30, 2024 – Since the rollout of the COVID-19 vaccine in 2021, fake news on social media has been widely blamed for low vaccine uptake in the United States — but research by MIT Sloan School of Management PhD candidate Jennifer Allen and Professor David Rand finds that the blame lies elsewhere.  In a new paper published in Science and co-authored by Duncan J. Watts of the University of Pennsylvania, the researchers introduce a new methodology for measuring social media content’s causal impact at scale. They show that misleading content from mainstream news sources — rather than outright misinformation or “fake news” ...

Historic iceberg surges offer insights on modern climate change

Historic iceberg surges offer insights on modern climate change
2024-05-30
(Santa Barbara, Calif.) — A great armada entered the North Atlantic, launched from the cold shores of North America. But rather than ships off to war, this force was a fleet of icebergs. And the havoc it wrought was to the ocean current itself. This scene describes a Heinrich Event, or a period of rapid iceberg discharge from the Laurentide Ice Sheet during the last glacial maximum. These episodes greatly weakened the system of ocean currents that circulates water within the Atlantic Ocean. The Atlantic Meridional Overturning Circulation, or AMOC for short, brings warm surface water ...

Reexamining misinformation: How unflagged, factual content drives vaccine hesitancy

Reexamining misinformation: How unflagged, factual content drives vaccine hesitancy
2024-05-30
What threatens public health more, a deliberately false Facebook post about tracking microchips in the COVID-19 vaccine that is flagged as misinformation, or an unflagged, factual article about the rare case of a young, healthy person who died after receiving the vaccine? According to Duncan J. Watts, Stevens University Professor in Computer and Information Science at Penn Engineering and Director of the Computational Social Science (CSS) Lab, along with David G. Rand, Erwin H. Schell Professor at MIT Sloan School of Management, and Jennifer Allen, 2024 MIT Sloan School of Management Ph.D. graduate ...

Novel virus identified in zebrafish from the pet trade causes disease in laboratory fish

Novel virus identified in zebrafish from the pet trade causes disease in laboratory fish
2024-05-30
Zebrafish in the pet trade are asymptomatic carriers of previously undescribed microbes, including a novel virus that causes hemorrhaging in infected laboratory fish, Marlen Rice from the University of Utah, US, and colleagues report in the open-access journal PLOS Biology, publishing May 23rd. Zebrafish (Danio rerio) are a common laboratory research animal, and they are also widely available as pets. In research laboratories, they are kept in specialized aquaculture facilities to prevent infectious disease, but zebrafish are occasionally ...

Cuckoos evolve to look like their hosts - and form new species in the process

Cuckoos evolve to look like their hosts - and form new species in the process
2024-05-30
The theory of coevolution says that when closely interacting species drive evolutionary changes in each other this can lead to speciation - the evolution of new species. But until now, real-world evidence for this has been scarce. Now a team of researchers has found evidence that coevolution is linked to speciation by studying the evolutionary arms race between cuckoos and the host birds they exploit. Bronze-cuckoos lay their eggs in the nests of small songbirds. Soon after the cuckoo chick hatches, it pushes the host’s eggs out of the nest. The host not only loses all its own eggs, but spends several ...

Cause of heart failure may differ for women and men

Cause of heart failure may differ for women and men
2024-05-30
A new study from the UC Davis School of Medicine found striking differences at the cellular level between male and female mice with heart failure with preserved ejection fraction (HFpEF). The findings could determine how HFpEF is treated in women compared to men. With HFpEF, the heart muscle contracts normally but the heart is unable to fully relax and refill properly between beats. This condition is known as diastolic dysfunction. It can occur if the heart is too stiff or if the contraction process doesn’t shut off quickly enough between ...

Tiny worm helps uncover long-lasting prenatal effects from amphetamines

Tiny worm helps uncover long-lasting prenatal effects from amphetamines
2024-05-30
Amphetamine is a psychostimulant that has been used to treat a variety of brain dysfunctions. However, it is a highly abused drug. In fact, amphetamine and amphetamine-derived compounds such as methamphetamine (Meth) are among the most abused psychostimulants in the world. The neurological effects caused by acute or chronic use of amphetamine have been broadly investigated and several studies have shown that proteins involved in the synthesis, storage, release and reuptake of dopamine (DA), a neurotransmitter that plays a role as in ...

Banners backfire: Misinformation impact on search results

2024-05-30
ITHACA, N.Y. – Cornell University researchers have found in a public health emergency, most people pick out and click on accurate information during internet searches. Though higher-ranked results are clicked more often, they are not more trusted. And the presence of misinformation does not damage trust in accurate results that appear on the same page. However, banners at the top of the search results page warning about misinformation decrease trust in accurate information, according to the research published in Scientific Reports. The relationship between ...

UC3M is a shareholder of five of its researchers’ new spin-offs

UC3M is a shareholder of five of its researchers’ new spin-offs
2024-05-30
The Universidad Carlos III de Madrid (UC3M) has become a shareholder of five new companies recently set up and promoted by different researchers: Applied Innovative Methods, Hiili, Persei Space, Seevia Technologies and 60Nd. UC3M participates in the share capital of its spin-offs in order to contribute to their business development. This minority and temporary shareholding is articulated in accordance with the regulations for the creation of knowledge-based university companies. AI Methods, S.L., led by Manuel Soler ...

New method makes hydrogen from solar power and agricultural waste

2024-05-30
University of Illinois Chicago engineers have helped design a new method to make hydrogen gas from water using only solar power and agricultural waste, such as manure or husks. The method reduces the energy needed to extract hydrogen from water by 600%, creating new opportunities for sustainable, climate-friendly chemical production. Hydrogen-based fuels are one of the most promising sources of clean energy. But producing pure hydrogen gas is an energy-intensive process that often requires coal or natural gas and large amounts of electricity.   In a paper for Cell Reports Physical Science, a multi-institutional ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

State gun laws and firearm-related homicides and suicides

Use of tobacco and cannabis following state-level cannabis legalization

Long-term obesity and biological aging in young adults

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

[Press-News.org] New, modified CRISPR protein can fit inside virus used for gene therapy
Novel enEbCas12a protein shows potential promise as gene-editing tool to one day treat disease